Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

Université de Montréal

$27,000.00

Fabrication of a library of porous template hydrogels for therapeutic applications in oral delivery

FY 2024-25

Summary
Phenylketonuria (PKU) is a genetic disorder that prevents the body from properly metabolizing the amino acid phenylalanine (Phe). This leads to toxic accumulation that can cause significant brain damage if left untreated. An enzyme found in plants, phenylalanine ammonia-lyase (PAL), helps eliminate excess Phe by catalyzing its conversion into trans-cinnamic acid and ammonia without requiring cofactors. While there is an injectable therapeutic option available, it is associated with considerable side effects, which affect treatment adherence. Our project proposes the development of a new oral treatment method. The PAL enzyme would be encapsulated in a porous gel, preventing its release while allowing for the elimination of Phe in the small intestine. Our gel prototype has demonstrated the ability to contain large amounts of PAL without immediate release. However, laboratory tests revealed that 40% of the enzyme is released in an environment simulating the intestine. Therefore, we aim to improve this gel to maintain enzyme activity in the intestine while minimizing excessive release. We will create a library of ultra-porous gels by adjusting several parameters, such as chemical structure and manufacturing methods, to optimize their capacity to contain and protect the PAL enzyme. We hope that, in the long run, this technology can be applied to other metabolic diseases.
Program
Master's Award: Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
530044
Name
Nadeau Catherine
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Fabrication of a library of porous template hydrogels for therapeutic applications in oral delivery
Programtype2
Studentship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Controlled Release; Enzymes; Library; Metabolism; Oral Administration; Pharmaceutical Technology; Phenylketonuria; Polymers; Porous Hydrogel; Template
Abstract
Phenylketonuria (PKU) is a genetic disorder that prevents the body from properly metabolizing the amino acid phenylalanine (Phe). This leads to toxic accumulation that can cause significant brain damage if left untreated. An enzyme found in plants, phenylalanine ammonia-lyase (PAL), helps eliminate excess Phe by catalyzing its conversion into trans-cinnamic acid and ammonia without requiring cofactors. While there is an injectable therapeutic option available, it is associated with considerable side effects, which affect treatment adherence. Our project proposes the development of a new oral treatment method. The PAL enzyme would be encapsulated in a porous gel, preventing its release while allowing for the elimination of Phe in the small intestine. Our gel prototype has demonstrated the ability to contain large amounts of PAL without immediate release. However, laboratory tests revealed that 40% of the enzyme is released in an environment simulating the intestine. Therefore, we aim to improve this gel to maintain enzyme activity in the intestine while minimizing excessive release. We will create a library of ultra-porous gels by adjusting several parameters, such as chemical structure and manufacturing methods, to optimize their capacity to contain and protect the PAL enzyme. We hope that, in the long run, this technology can be applied to other metabolic diseases.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Nadeau, Catherine
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~